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Objrctiws. To determine whether spectral measurps of heart 
period (RR) variability predict dealh when measured Isle after 
infarctkm, we studied patients in the Cardiac Arrhythmia Pilaf 
Study (CAPS) who survived far I year and had a 24.b elecirecar- 
disgrsphic (ECG) recording made after the CAPS drug ra 
sashed out. 
Background. Four components of the heart period power 
speetrmn-ultra tow freqwncy t:o.n033 Hzl. very low rrequency 
(0.0@.3 to <O&4 Hz), low frequency (0.04 w <0.15 Hz) and high 
frsqucncy power (0.15 to <tl.dO Hz)-plus total power (1.157 x 
IO-” to <O&l Hz) and the ratio of tow to high frequency power 
predict msrtatlty when measured <Jo days after myocardial 
infarction. However, these vartnbles increase to steady state 
vahres by 3 monthsaNer infarction and the prognosttc signit?canee 
of recovery values is uttknowo. 
Merhsds. The 24-b power spectral density was computed from 
We (I) have shown that, on average, measures of heart 
period (RR) variability drop to 25% to 5m of normal at the 
time ofacute mywardial infarction a d increase to stabb but 
below nonnal values by 3 months afterwards. Low values of 
many measures of heart period variability assessed 1 to 2 
weeks after myocardiai infarction are associated with an 
increased risk ofcardiac death in subsequent years (2-6). It 
is not known whether heart period variability assessed after 
recovery from myocardird infarction predicts subsequent 
mortatity. The purpose of this study was to determine 
whether heart period variability measured I year aRer myo- 
cardial infarction Txedicted subsequent mortality. 
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ECG recordings made I year after infarcttea astan fast Pourkr 
transform5 and the six measures listed were esktdated. 3 ke v&es 
wrre dichotomized at cut paints that q ardmfred the ssseehtten 
with mortality. 
Resul& Each measure of RR variabttity had a svcog nod 
significant univartate association with mort.9ltly; the r&rive risks 
for Ihese vnrinbles ran@ frdm 2.5 to 5.6. A&r ad&shnrot for 
age. New York Heart Assastatioa ftmedonaf class, rates in Ibe 
coronary c*re unit, left ventrbxdar ejacttnrr RacRett and renttic- 
ular arrhythmias. some measures of heart txrtod vartabgtt~ stttt 
Methods 
Patient sample. We studied patients who participated in 
the Cardiac Arrhythmia Pttot Study [CAPS) to address the 
question whether heart period variability assessed I year 
after myocardial infarction predicted mortality during 218 
months of follow-up. The 10 CAPS clinical centers enrolled 
502 patients between 6 and 60 days after myocardiat infarc- 
tion (71. To qualify for CAPS, palients had to have an 
average of 210 ventricular premature complexes (VPCs)lh 
in a 24-h continuous electrocardiographic tECCi) recording. 
Participants were randomized to one of four active treatment 
limbs or to olacebo treatment and then were followed up for 
I year. At the end of I year, 401 patients had a 24-h ECG 
recorded 2 I week after stopping their CAPS stndy medica- 
tion. Patients had ECG recordings made out of hospital; the 
CAPS orotocol did not srecifv the activity level during the 
record& except to en&rage nannat d&y activities. of 
the 401 patients who had a washout 24-h ECG recording, 50 
were prescribed open label amiarrhythmic drugs immedi- 
ately after the washout 24-h ECG recording, leaving 351 
patients who were discharged with the intent not to treat 
with anv andarrhvthmic drw. We attempted to reamlyre ail 
of the 351 recordings that were available to calculate several 
measures of heart period wrriabiity, bum 20 could not be nscd 
for the following reasons: tape missing or malfunctioned 
(n = 9); tap: too noisy (n * 6); atria1 fibrillation (n = 2): 
junctional rhythm (n = I); alrioventricular (AV) block (n = 
I), and paced rhythm (n = I). 
~ottow-up. Patients were enrolled in CAPS between July 
25, 1983 and AugW 21, 1985; follow-up for each patient 
ended on the I-vear anniversarv of his or her enrollment. TO 
obtain the status of patients afikr the end of CAPS, the nine 
clinical centers in the United States used the National Death 
Index, which searched for status based on the participants’ 
name, birth date and social security number (8). The Cana- 
dian site conducted a separate follow-up of its patients. In 
1990, the status (living or dead) on December 31. 1987 was 
determined for all patients. Because cause-specific mortality 
is not -eliabIy available from the National Death Index, we 
used all-cause mortality as the end point for survival analy- 
ses. 
Processing of H-hour Halter recordings. We retrieved the 
tape or cassette recordings from the CAPS Data Coordinat- 
ing Center and attempted to reprocess all of them usiag 
recently described methods (9.10). Briefly. the 24-h record- 
ings were digitized by a Marquette 80+0 scanner and submit- 
ted to the standard Marquette algorithms for QRS labeling 
and editing (version 5.7 software). Then, the data files were 
transferred by high speed link from the Marquette scanner to 
a Sun 4175 workstation where a second stage of editing was 
done, using algorithms developed at Columbiq University, to 
find and correct any remaining errors in QRS labeling that 
could adversely affect measurement of heart period variabii- 
ity. For a tape to be eligible for this study, we required it to 
have 212 h of analyzable data and have at least half of 
the nighttime (midnight to 5 AM) and daytime (7:30 AM to 
9:3C ~tihi) peiiods analyzable. At least 50% of each period had 
to be sinus rhythm. We excluded 20 patients from the 
analysis of heart period variability for one or more of the 
reasons listed above. 
Time series analysis of nomml RR Lutervals. After the 
second slage of editing and review of the results by a 
cardiologist, the heatl period power spectrum was computed 
over the entire recording interval (usually 24 h) using a 
method rst described by Albr,cht and Cr’len (9). Our 
adaptation of the method was described by Rottman et al. 
(IO). First, a regularly spaced time series was derived from 
the RR intervals by sampling the irregularly spaced series 
defined by the succession of normal RR intervals. For each 
Holler ECG recording, 2’spoints were sampled; for record- 
ings precisely 24 h in duration, the sampling interval was 
329 ms. A “boxcar” low pass filter with a window twice the 
sampling interval was then applied. Gaps in the time series 
resulting from noise or ectopic beats were filled in with linear 
splines (9). A fast Fourier transform was computed and the 
resulting power spectrum was corrected for the attenuaring 
effects of both the filtering and the sampling (9). For a 
recording exactly 24 h long, the effective frequency range for 
this method is from I. 1574 x 10-I Hz to >0.40 Hz (periods 
of seconds to hours). Finally, frequency domain mea&es of 
heart period variability were computed by integrating over 
their frequency intervals, for example, 0.04 to 0.15 Hz for 
low and 0.15 to 0.40 Hz for high frequency power. 
We computed the 24-h power spectral density and calcu- 
lated the power within four frequency bands: I) <0.0033 Hz, 
ultra low frequency power; 2) 0.0033 to <O&l Hz. very low 
frequency power. which shows a relative increase in patients 
with congestive heart failure (I I) and is the lowest frequency 
band that can be estimated by our S-min method (IO); 3) 0.M 
to co.15 Hz, low frequency power, which reflects modula- 
tion of sympathetic or parasympathetic tone by baroreliex 
activity (121, and 4)0. IS to ~0.40 Hz, high frequency power, 
which reflects modulation of vagal tone, primarily by breatll- 
ing (13,14). !n addition, we calculated total power (power in 
the band <0.40 Hz) and the ratio of low to Ligh frequency 
power. a measure that has been used as an indicator of 
sympathovagal balance (15). High values for the ratio sug- 
gest predominance of sympathetic nervous activity. 
Statistical me’Mds. Because the distributions of mea- 
surcs of hean period variability are extremely skewed to the 
right, the log transformation of these measures was applied 
before the data were summarized. Geometric means were 
calculated by taking the antilogarithms of the logarithmic 
means. 
Survival analysis mathads. We calculated Kaplan-Meier 
survival functions (16) to display graphically the survival 
experience ofthe CAPS patients over an interval of time up 
to 3 years after the 12-month washotit Holter recording at the 
end of CAPS, and to tabulate survival rates up to a prespec- 
ited time, 3 years. We performed Cox proportional hazards 
analyses (17) when testing hypotheses about the assticiation 
between one or more risk predictors and mortality. The Cox 
analysis also provides a measure of association. the hazard 
ratio, that is not linked to a single time point. The P2L 
BMDP computer program was used to carry out the Cox 
sunival analyses (IS). This program permits categorical and 
continuous F .&or variables to be analyzed together. The 
Cox proportional hazards model produces estimates of the 
independent &acts of each of several predictor variables on 
survival (17). The hazard function, which is pmportional to 
the instantaneous probability of dying a1 any point in time, is 
assumed in the Cox modI:1 to h proportional to the expo. - - 
nential function exp(ZBiXi), wheie the B’s are the regression 
coefficient and the X’s are the values of the predictor 
variables. The values of the regression coefficients are 
assumed to remain constant over time, and each exp(BJ is 
interpretable as a relative risk for variable i: exp(&) is the 
ratio ofinstantatteous probabilit’es ofdying for patients with 
values of Xi I unit apart, holding all other variables constant. 
Statistical significance was assessed by referring 2, the 
estimate of the regression coeftitient B divided by its stan- 
dard error, to the standard norma! distribution. 
All cavariatas except left ventricular ejection fraction 
WC~E measured at approximately the time of the I-year 
Holtcr recording. The covariates were I) age, coded on a 
%int.:rval scale (<50,50 to 59, and ~60); 2) the presence or 
absence of rales; 3) the presence or absence of congestive 
heart failure; 4) the baseline left ventncular ejection frac- 
tion, coded on a four-interval scale (<O.ZO. 0.20 to <0.30. 
0.30 to ~0.40. and ~0.40). and rhe following Halter vati- 
ables: 5) average nmmal to normal RR imerval, dichoto- 
mized at 700 ms, 6) average VPCsih. dichotomized at IO/h. 
and 7) presence or absence of unrustaincd VPCs. 
Dichotomizing the measures of heart period variability. 
For ease of communication and for eventual clinical use. ae 
dichotomized the six measures of hearr penod variaMitv 
when estimating their association with morta.lity. Fur each. 
we sought the dichotomization point that maximized the 
hazard ratio from a Cox proportional harards regression 
model (17) for comparing patients below the cut point 
(expected to be at high risk) with those at or above it 
(expected to be at low risk). The hazard ratio is the standard 
statistical measure for comparing two survival functions 
when the Cox proportional hazards model obtains. Given 
oar knowledge of cut points for other measures. and gtven 
the need for adequate numbers of patients for testing hy 
potheses. we restricted our search to dichotumirations in the 
interval between 10% low: 90% high and 32n low: 65% high. 
We calculated the hazard ratio for each pusaibif dichotomi- 
zation point within this interval (unadjusted for any covari- 
ales). identified the point at which the hazard ratio attained 
its maximum and then rounded to titp nearest multiple of 5. 
IO or 100. 
Results 
Of the 502 patients who enrolled in CAPS. 401 had a 24-h 
ECG recording performed while the patient was taking no 
antiarrhythmic drugs 1 year after the index myocardial 
infarcarction. The 331 patients whose physicians chose to 
follow rhem in the absence of antiarrhyihmic drugs and who 
had adequate 24-h ECG recordings made 402 ? 21 days after 
myocardial infarction were the subjects of this study. For the 
331 patients who were included in this report, 30 deaths 
occurred during an average follow-up period of 788 ? 222 
days (range 14 to 1,240). Table I shows clinical characteris- 
tics of the 331 patients who participated in !his study. The 
mean age was 59 years, 84% were male. 26% had a myocar- 
dial infarction before the i&x infarction, the mean left 
-<entricular ejection fraction was 0.46. 30% had congestive 
heart failure and 22% were taking digitalis. The power 
spectral values for RR variability for the 331 patients were 
simitar to those of the placebo subgroup that we reported on 
previously (I). 
Hearl period variability and all-cause marialiiy. Table 2 
gives the significance and strength of the association be- 
tween l-year heart period variability and subsequent all 
caase mortality. For simplicity, each wiable was dichoto- 
mized at or near the cat point that gave tile strongest 
association with mortality. The dichotomizations put 10% to 
25% of the patients in the group with low values for 
measures of heart period variability. Other pos?ilfarction 
risk predictors that are available for the CAPS sample are 
Table 1. Characleristics of Meats Who Had a X-Hour 
Elocrrocardlographic IECG) Recording I Year 1402 e 21 days) 
After the Myocardial Ilrhrction That Qualified Them For the 
Cardiac Arrhrlhmia pilot Studv ICAPS) (n = 331) 
alsodisplayed for comparison. The graphic display of time to 
death for patient groups with high values for heart period 
variability versas groups with low values is shown in Figure 
I. tt is evident from the data in Table 2 that there are 
significant and sclong univariate associations between heart 
period variability and death. The low frequency/high fre- 
quency power ratio has the weakest association with death. 
The only other risk predictor that had an association with 
death that wac of comparable strength was congestive heart 
failure of recent onset. Using the cat points rhat were 
derived for the Multicenter Post Infarction Program (51, we 
found that only 3% to 5% of the CAPS patients were in the 
group with low v&es for measures of heart period variabil- 
ity. Nevertheless. these cut points Performed remarkably 
wzll. with most of the variables showing strong and sigaiti- 
cant associations with mortality in the l-year CAPS xmple. 
AS we found previously in another samp!e of postinfarction 
patients (61. every frequency domain measure of RR vari- 
ability in the CAPS sample is strongly correlated (r 2 0.901 
with a time domain measure. Also, the associalion of time 
domain variables withdeath is comparable to the association 
of frequency domain variables in the CAPS sample. 
Adjustment for eovarintes. Table 3 displays the relative 
risk for the heart period variability variables 1) unadjusted 
for any other&k predictors, and 2) adjusted for a numberof 
well known posiinfarction risk predictors one at a time by 
the Cox proportional hazards regression model. This proce- 
dure was done to identify previously studied covariates that 
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Table 2. Prediction of All-Cause Mortality Late After Myncardial Infarction byFrequency Domain 
Measures of Heart Period Variability and by Other PostiiljcLrction Risk Predicwrs 01 = 331*) 
Optimal cut pain,* 
Ultra low frequency <S.CHM lms9 pow 
Very tow irequency pawer <hoD (m?) 
LOW freqwncy power <I-D (rnS’1 
Hub trequency power <J5 tms’l 
Total .:6.wO In,?) pbwer 
LOW frequencylhigh frequency ratio C t .6 
MPtP cut points 
ultra tow frcqucccy power < 1.6w (rnP2) 
Very low frequexy power <I60 ims’) 
Low frequency <35 tmr$ puwer 
High frequency power <20(ms’) 
Tulal <Z.CW tms’) puwsr 
Low frequencyhigh frequency nria ~0.95 
67 3.10 3.4 
73 4.62 5.6 
&I 4.69 5.6 
48 3.25 3.6 
66 3.29 3.4 
64 2.42 2.5 
I0 3.06 5.2 
14 0.74 1.7 
14 2.76 4.5 
18 I .42 2.4 
IO 3.06 5.2 
18 I.26 2.2 
I% 2.13 
;: 1.18 
21 1.58 
23 0.95 
98 1.79 
97 0.28 
40 I.60 
53 2.66 
2w ISQ 
2.5 
2.1 
2.4 
1.8 
4.2 
1.1 
2.1 
2.8 
2.3 
Unsustained VT an Holler ambular.ny ECG 79 2.15 1.7 
‘Except rale~ in carmary cmunit (n = 31 IIand congestive heti failure at baseline In = 328). $2 1 I.%, p < 
0.01 Z t 2.58. p C 0.01; Z E 3.30. p < O.CQI, ?Probabilily of dying ii in “pwr” catcg~ry/Prob~bitity of dying if in 
*‘god’ CLCEWY. PMearurments made al baseline. ECG = cteclrocardiapram. MPtP = Mutlicl-nler Part t&&on _ 
Pwram; VPC = ventricular premature complexes: VT = ventricular tachycardia. 
possibly shared predictive information with heart period 
variability. None of the variables that were examined in this 
way weakened substantially the prediction of death by heart 
period variability. This was true when the CAPS cm points 
were used and also when :he cul points previously esiab- 
lished in the Multicenter Post Infarction Program data ret 
were used (5). 
To assess the prediction of death by measures of heart 
period variability independent of the other risk predictors, 
we again used the Cox proportional hazards regression 
model. Sever risk predictors were put in the model and 
forced to stay in. Then, the measures of heart period 
variability were studied one at a time. Figure 2 shows the 
effect of adjustment on the survival curves and Table 4 gives 
the 2 scores and relative risks (hazard ratios) after adjust& 
for the seven other risk predictors. Very low and low 
frequency power were strong and significant predictors of 
death even when statistically adjusting for other important 
risk predictors. The other frequency domain measures of 
heart period variability had reasonably strong asso&tions 
with mortality, but lost their statistical significance after 
adjustment for the covariates. 
Only about one third of the patients who were in the low 
(high risk) group for measures of heart period variability at 1 
year were in the low group at baseline (see Fig. 3). We 
conducted several analyses, using the Co% regression model, 
to determine whether there was information in the baseline 
(25 5 17 day) measures of RR variability, independent of the 
information in the I-year measures, that added to the pre- 
diction of outcome after I year. The I-year measures were 
analyzed both as measured and after dichotomization, and 
the baseline measures were analyzed both as measured and 
as change scores from baseline to I year. Considering the 15 
tests each performed at a nominal significance level of 0.05, 
baseline information did not improve prediction of all-cause 
mortaiily occurring 21 year after myocardial infarction. 
Previously, we showed that speclral measures of heart 
period variability recovered by 3 months after myocardial 
infarction (I). The sample of 331 patients in the present study 
inclnded 14patients who had recurrent myocardial infarction 
between the index infarction and the t-year washout record- 
ing (5 patients died during long-term follow-up). To account 
for the possible influence of recumnt infarction on our 
results, we excluded these 14 patients and repeated all of the 
analyses. The results of these analyses were similar to those 
thaw included the patients with recurrent infarction: after 
Figure 1. Kaplan-Meier survival curves for 
331 patients in the high or low category 
(optimal eat points) for the four mutually 
exclua;ve freqoency domain mensures of 
heart period variabiliry. ultra low frequency 
(ULF), very low frequency (VLF), low fre- 
quency ILF) and high frequency (HF) paher. 
using all cause mortality as the end point. 
The number oi patients at the start of follow- 
up, anti the number known to be alive and 
l&g followed up after I, 2 and 3 years acre 
as follows: high ULF. 264. 157. 160.23: low 
ULF, 67,63.33,4; high VLF. 258. 254. 159. 
24;low VLF, 73,66.34,3: high LF, 267.261, 
165, 24: low LF. 64. 59. 28. 3: high HF. !83. 
276, 171, 26: low HF. 48.44. 22. I. 
exclusion of the 14 patients with reinfarction. the ossocia- 
lions between measures of heart period variability and death 
were slightly stronger and slightly less sigmficant. 
Discussion 
Heart period variability and prediction of late death. The 
primary objective of this study was to determine whether 
heart period variability measured I year after myocardial 
infarction would predicl death from all causes during subse- 
Year After Washout Tape 
quent follow-up. We have already shown that many mea- 
sures of heart period variabilify made within 2 weeks of 
acute myocardtal infarction have a strong, statistically sig- 
nificant, and independent association with mortality overthe 
next ? to 3 years (2.5.6). However. there are. reasons to 
question whether heart period variability measured late, that 
is. I year ner myocardial infarction. will predict subsequent 
death I) There are many deaths and nonfatal myocardi?! 
infarctions occurring in the 1st year after myocardial infarc- 
tion that might change the risk profile of I-year survivors 
lnhle 3. Un djusted and Adjusted Relative Risks of All-Cause hlurlslity Predicted by Frequency 
Domain Me,tsures of Heart Period Variability Dichotomized al Ihe Omimal Cut Points In = 331) 
ULF “LF LF HF TP LFMF 
5.6 5.6 
4,9 4.9 
5.6 6.5 
59 5.9 
s.s 5.6 
4.1 4.1 
Sh 1.6 
5.0 I.0 
5.4 5.4 
5.s 5.4 
1.6 3.4 25 
3.2 2.9 ?.I 
2.8 1.6 3.0 
3.5 3.4 2.6 
3.5 3.3 2.5 
2.4 2.2 1.9 
3.6 3.4 ?.I 
2.7 2.7 1.2 
3.3 3.1 2.3 
3.3 3.2 2.8 
ULF VLF 
1.0 
Year After Washout Tape 
(19). 2~ There is substantir\l recovery of heart period vari- 
ability values toward normal during the first year after 
myocardial infarction (11. This recovery might decrease the 
predictive value far death when RR period variability is 
measured late after myocardial infarction. Third, it has been 
shown that low values for measures of heart period variabil- 
ity fail to predict death in hypertrophic cardiomyopathy, a 
cardiovascular disease in which sudden cardiac death ac- 
counts for a substantial fraction of all deaths (20). The latter 
findine sueee~ts that low values for measures of heart aeriod 
variatkt& not predict death in all cardiac disease;. 
Nevertheless. we did find. after all. that heart period 
Table 4. Measures of Heart Period Variabiliry: Asvocialion With 
AIKause Mortality, Adjusted for Age: Congeslive Heart Failure, 
Rales. Left Ventricular Ejection Fractmn, Average RR Interval. 
and Two Ventricular Arrhythmia Variables (n = 3301* 
ultra low frequency power 1.31 1.8 
very low frequency power 3.20 4.4 
Low frequency power 2.87 3.8 
High frequency power 0.93 1.6 
Total power I.11 1.7 
Low frcuxncyfhigh frequency ratio I .66 2.0 
Figure 2. Survival curves for patients in 
the high or low category (optimal cul 
points) for the four mutually exclusive 
kquency domain measures of heart pe- 
nod variability, ULF. VLF, LF, and HF 
~mver. using all-cause mortality as the end 
r&t. These curves were &ted by the Cox 
method for the 330 patients who had ade- 
P late Halter ECG dam and values for all 
seven covariater. Thick Ii& represent “n- 
atljusted heart period variability data and 
lhii lines represent data adjusted for the 
covariates: age, congestive heart failure 
during the 1st year, r&s at I year. radio- 
nuclide ejection fraction, average RR 
interval. the frequency of ventricular 
premature complexes and unsustained 
ventricular tachycardia on the Holler ECG 
recording. [n each panel, the tap hw 
curves are for patients in the high category 
and the lower two curves are for patients in 
the low category. The number of patients 
at the start of follow-up, and the number 
known to be alive and being followed up 
after I. 2 and 3 years were as follows: high 
ULF. 263,257. MI. 23: low ULF, 67,63, 
3% 4: high VLF, 257, 254. 159, 24; low 
VLF. 73.66,34,3; high LF, 266.261,165, 
24; low LF, 64, 59. 28, 3; high HF, 282. 
276, 171.26; low HF.48.44.22. 1. Abbre- 
viations a6 in Figure I. 
variability measured I year after myocardial infarction pre- 
dicted death from all causes during subsequent follow-up. 
The association between measures of heart period variability 
and subsequent death was strong and was statistically sig- 
nificant despite the modest power of this study (a relatively 
small sample size and a modest number of deaths that 
occurred during follow-up). Furthermore, even with mar- 
ginal statistical power, we were able to show that measures 
of heart period variability predict subsequent deaths inde- 
pendent of other well known postinfarction risk predictors, 
such as heart failure, left ventricular ejectiun fraction and 
ventricular arrhythmias (frequent WCs or nonsustained 
ventricular tachycardia. for example). 
The finding of strong and independent associations be- 
tween measures of heart period variability made I year after 
infarction and subsequent deaths from all causes was im- 
pressive. Farrell et al. (41 reported that a measure of very 
low frequency RR variability is a better predictor ofarrhytb- 
mic events (sudden cardiac death, nonsustained ventricular 
tachycardia or ventricular fibrillation) than of nonsudden 
deaths or nonfatal myocardial infarctions. If the predictive 
value of heart period variability measures has some speci- 
ficity for arrhythmic events late after myocardial infarction 
as it does early, then the association betceen low values for 
heart period variability and arrhythmic events must be 
strong indeed considering the relatively strong associatbx 
with death of all causes. 
CAPS l-Year Survivors 
Figw? 3. Comparison of baseline values for the natural logarithm of 
total power wilh the I-year values. Most of the wints lis above the 
diag&M line of identiiy indicating that, on a&rage. total power 
increases during the year atler myacardml infarction. The veriical 
dolled line indicates the dichotomization value (7.60. corresponding 
LO a cut point of 2,ooO ms’) to classify the patients into low and high 
risk groups during the 1st month after inhrclion. The horizontal 
dotledlii indicates the dichotomization vahtc 18.70. corresponding 
to a cut point ofb,OCQ ms’t lo classify the patients into low and high 
r;.w gxours late after infarction. About half of Ihe patients who had 
low 6al,, for total power at baseline u,erc in th; low group at I 
year. About Iwo thirds of the patients in Ihe lowgroupal I year were 
in the high group al baseline. The black dots indicate palientr who 
died between I and 3 years after infarction. Late deaths were 
associated more strongly with I-year values for total power than 
with bzseline values. 
Isrue of covruiatc adjustment. In measuring the indepen- 
dent predictive value of measures of heart period variability. 
the issue of covariate adjustment should be considered. We 
adjusted for the incidence of congestive heart failwe over 
the year between enrollment and the I-year follow-up. Th? 
frequency of VPCs and the prevalence of nonsustained 
ventricular tachycardia were assessed in the same 24-h ECG 
recording in which heart period variabilit) -.vas measured. 
This recording was made an average of 402 days after 
myocardial infarction. However. left venrricular ejection 
fraclion was measured within 60 days of myocardial infarc- 
tion imean 18 L I9 days) as the baseline for CAPS. Deaths 
and laonSatal myocardial infarctions occurring between en- 
rollment and l-year follow-up may have changed the distri- 
bution of IzSt ventricular ejection fracraction i  the patients who 
survived to I year after infarction. Such changes may 
account for the weak association between left ventricular 
ejection fraction and death that occurred subsequently in 
patients who survived I year after myocardbl infarction. 
However, this may not be the only euplnns~ion; we found 
previously (21) that left ventricular ejection fraction does not 
predict late deaths after infarction nearly as well as it 
predicts early deaths. Nevertheless. it would have been 
better to measure left venrricular ejection liaction ! year 
after infarction zs was done for ventricular arrhythmias and 
heart period variability. 
~rcqucmy of VF0. This frequency decreased between 
qualification for the study. 6 to 60 days after myocardial 
InfarctIon. and I year later. Almost one third of the patients 
had 4 IO VPC,% in the washout 24-h ECG dcae at the end of 
CAPS. The decrease in ventricufar arrhythmia frequency 
I year &tcr myocardial infarction may be attributed to three 
fmors: I) deaths occurring preferentially in patients with a 
gea:er frequency of VPCS between enrollment xd 1 year. 
21 spontaneous variabiliry in venti~cular arrhqlhmias, aud 
31 regression to rhe mean (22-24). &spire the decrease in 
frequency of ventricular Xrhythmids far the CAPS group as 
a whole. vcnrriculararrhythmias detected : yearaSterinfarc- 
lion were excellent predictors of subsequent all-cause mor- 
tality (25). 
Comparisons with Mdticeoter post Infarctic7 F%ogg. 
In the Mulucenter Post Infarction Program sample. ultra low 
frequency power FKI its corresponding time domain vari- 
able. SDANN index. had the strongest univariate associa- 
tions with monality and the associations remained strong 
after adjustment for the same covariates used in this srudy 
0.6). In lhe present study of the CAPS patients who 
survived I year. very low frequency power had the strongest 
association Gth all cause mortalily. Th!s minor di&rence is 
likely to be due to the play of chance in a relatively small 
sample (only 30 deaths occurred during follow-up). Also, a 
difference in selecrion criteria in the two studies resulting in 
d&rent samples could account for pru? of the difference in 
results between the Iwo studies. Overall. the results OS the 
IWO studies are remarkably similar. 
Particularly notable was the exceltent performance in 
CAPS of the cut points Found in the Multicenter Post 
h~hrction Program despite the substantial recovery in mea- 
sures of heart period variability that occurs by I year after 
myocardial infarction (I). This result represents a validation 
of the use of the cut poirns found in the Multicenter Post 
Infarction Program fur providing partitions between high 
risk and low risk patients (5). In the latter study, the optimal 
cut points were found relrospectively, whereas, in the cur- 
rent study. the cut point values of the Multicenter Post 
Infarction Program could be and were specified prospec- 
tively. By the same take?, the optimal cut points Sound in the 
present study were determined retrospectively, and thus 
might be biased. Given [he similar (and strong) relative risks 
associated with the Multicenter Post Infarction Program and 
the “oplimal” cut points found in this study, we expect thai 
the true optimal cut points for prediction I year afier 
infarction lie belween the two. 
Limitations and implieatiom of the study. Using patients 
recruited for a randomized controlled clinical trial to evalu- 
ate a risk predictor raises questions about the generalizabil- 
ity of the findings. The CAPS sample was enrolled in IO 
medical center, in the United Slates and Canada; therefore, 
it is more likely to be representative of patients in the United 
States and Canada lhan would a sample drawn from a single 
center. On the other hand, the sanple was selected from the 
upper quintile of the WC frequency distribution. It should 
bc kept in mind that the CAPS group al baseline is not a 
represernative sample of the postinfarction population in the 
participating centers. Nevertheless, VPC frequency, the 
variable used to qualify patients for CAPS. has only a weak 
association with IefI ventricular ejection fraction (21,26,27) 
and almost no association with measures of heart period 
variability (2,5,6). As a r:xult of the weak associations 
between ventricular arrhythmias and left ventricular ejection 
fraction (21,27) or heart period variability (I), the mean 
values for left ventricular eiection fraction and for measures 
of heart period variability ire similar in the CAPS patients 
and the Multicenter POSI Infarction Program patients (which 
is a representative sample of postinfarction patients in the 
United States). The only difference for heart period variabil- 
ity variables between the two studies was an 8% lower 
average value for high frequency power in the CAPS sample 
that could be atttbuted to the greater linear splining in the 
region of VPCs in CAPS recordings or to the time of the first 
postinfarction 24-h ECG recording (I I + 3 days for the 
Multicenter Post Infarction Program and 25 ? 17 for CAPS) 
(I). Although the present results should be generalized 
cautiously, there is reason to believe that the findings may be 
applicable to patients with chronic coronary heart disease. 
However, prudence dictates performance of additional stud- 
ies to verify the generalizability of the results obtained in the 
CAPS sample. 
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